Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Audentes Therapeutics Inc (BOLD)

24.98 -0.07 (-0.28%)

10/20/2017  4:00pm

Open:

25.36

Pre. Close:

25.05

High:

25.52

Low:

24.94

Volume:

229,337

Market Cap:

694.04M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

-

-

Low:

-

-

Close:

-

-

Technical analysis  (as of: 2017-10-20 4:33:59 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 34.79     One year: 39.05

Support:

Support1: 23.89    Support2: 19.88

Resistance:

Resistance1: 29.79    Resistance2: 33.43

Pivot:

26.44

Moving Averages:

MA(5): 25.11     MA(20): 27.13

MA(100): 21.36     MA(250): 18.28

MACD:

MACD(12,26): 0.15     Signal(12,26,9): 0.65

%K %D:

%K(14,3): 14.09     %D(3): 12.43

RSI:

RSI(14): 44.23

52-Week:

High: 33.43  Low: 13.13  Change(%): 44.8

Average Vol(K):

3-Month: 16899  10-Days 7838

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
BOLD has closed above bottom band by 18.4%. Bollinger Bands are 4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 27 Sep 2017 12:11:15 GMT
Audentes Therapeutics Announces Rare Pediatric Disease and Fast Track ...

Fri, 20 Oct 2017 18:33:45 GMT
Right Time To Pull Money Out Of Audentes Therapeutics, Inc. (BOLD), Cigna ...

Mon, 17 Apr 2017 20:02:37 GMT
Audentes Therapeutics Announces Proposed Public Offering of Common Stock

Tue, 13 Jun 2017 12:00:00 GMT
Audentes Therapeutics Appoints Jennifer Jarrett to Board of Directors

Mon, 20 Mar 2017 12:00:00 GMT
Audentes Therapeutics Announces Presentation Of Data From RECENSUS, A Medical ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

Shares Float (M)

13.41

% Held by Insiders

3.30

% Held by Institutions

91.94

Shares Short (K)

637

Shares Short Prior Month (K)

567

Stock Financials

EPS

-5.590

EPS Est. Current Year

-3.500

EPS Est. Next Year

-3.690

EPS Est. Next Quarter

-0.920

Forward EPS

-3.690

Book Value (p.s.)

5.830

PEG Ratio

-1.63

Profit Margin

Operating Margin

Return on Assets (ttm)

-33.0

Return on Equity (ttm)

-63.3

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-2.643

Qtrly Earnings Growth

Operating Cash Flow (M)

-56.48

Levered Free Cash Flow (M)

-39.04

FoxReading.com

Valuation

P/E

-4.47

P/E Growth Ratio

P/BV

4.28

P/S

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.